<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.opportunitymonitor.v1.DrugRecordOutput xmlns:ns2="local" id="9680"><DrugName>UR-12460</DrugName><DrugSynonyms><Name><Value>UR-12460</Value><Types><Type>Research Code</Type></Types></Name><Name><Value>149691-90-7</Value><Types><Type>CAS RN</Type></Types></Name></DrugSynonyms><CompanyOriginator id="20513">Grupo Uriach</CompanyOriginator><CompaniesSecondary><Company id="20513">Grupo Uriach</Company></CompaniesSecondary><CrossReferences><SourceEntity id="9680" type="Drug"><TargetEntity id="190114" type="siDrug">UR-12460</TargetEntity></SourceEntity><SourceEntity id="20513" type="Company"><TargetEntity id="4296758268" type="organizationId">Uriach y Compania SA</TargetEntity></SourceEntity><SourceEntity id="325" type="ciIndication"><TargetEntity id="D013923" type="MeSH"></TargetEntity><TargetEntity id="-338631668" type="omicsDisease"></TargetEntity><TargetEntity id="306" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="312" type="Action"><TargetEntity id="3554" type="Mechanism">Platelet Adhesion Inhibitors</TargetEntity><TargetEntity id="3985" type="Mechanism">Drugs Targeting on PolyQ-expanded Proteins</TargetEntity></SourceEntity><SourceEntity id="299" type="Action"><TargetEntity id="346" type="Mechanism">Platelet-Activating Factor Receptor (PAFR) Antagonists</TargetEntity></SourceEntity><SourceEntity id="PTGT-01502" type="ciTarget"><TargetEntity id="149040958157243" type="siTarget">Platelet-activating factor receptor</TargetEntity><TargetEntity id="2774" type="omicsTarget"></TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="DX">Discontinued</PhaseHighest><PhaseTerminated id="DR">Discovery</PhaseTerminated><IndicationsSecondary><Indication id="325">Thromboembolism</Indication></IndicationsSecondary><ActionsPrimary><Action id="299">Platelet activating factor receptor antagonist</Action></ActionsPrimary><ActionsSecondary><Action id="312">Platelet aggregation inhibitor</Action></ActionsSecondary><Technologies><Technology id="762">Small molecule therapeutic</Technology></Technologies><EphmraCodes><Ephmra><Code>B1C</Code><Name>PLATELET AGGREGATION INHIBITORS</Name></Ephmra></EphmraCodes><LastModificationDate>2017-09-01T05:31:32.000Z</LastModificationDate><ChangeDateLast>2005-06-14T16:15:25.000Z</ChangeDateLast><AddedDate>1996-02-16T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;Uriach has discontinued further investigation of &lt;ulink linkID="9680" linkType="Drug"&gt;UR-12460&lt;/ulink&gt;, a PAF antagonist for the potential treatment of thromboembolism, because of problems with chemical stability [&lt;ulink linkID="174894" linkType="reference"&gt;174894&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="20513">Grupo Uriach</Company><Country id="ES">Spain</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="5">Other</DiscontinuedReason><Indication id="325">Thromboembolism</Indication></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="20513">Grupo Uriach</Company><Country id="ES">Spain</Country><DevelopmentStatus id="DR" sortOrder="7">Discovery</DevelopmentStatus><Indication id="325">Thromboembolism</Indication><Source id="174894" type="CORPORATE"></Source></DevelopmentStatusHistoric></IDdbDevelopmentStatus><Targets><Target id="PTGT-01502"><Name>Platelet activating factor receptor</Name><SwissprotNumbers><Swissprot>P21556</Swissprot><Swissprot>P25105</Swissprot><Swissprot>P35366</Swissprot><Swissprot>P46002</Swissprot><Swissprot>Q62035</Swissprot><Swissprot>Q9GK76</Swissprot><Swissprot>Q9TTY5</Swissprot><Swissprot>Q9XSD4</Swissprot></SwissprotNumbers></Target></Targets><ReasonsForUpdate><ReasonForUpdate><Reason>Indexing Updated</Reason><Description>Indexing updated</Description></ReasonForUpdate><ReasonForUpdate><Reason>Patent Added</Reason><Description>Patent Added:  &lt;ulink url="utility.patent?i_patent_id=IN2249879" linkType="patent" linkID="IN2249879"&gt;EP-00525768&lt;/ulink&gt;</Description></ReasonForUpdate></ReasonsForUpdate><StructureSmiles><Smiles>Cc1c(cccn1)C(C#N)N2CCN(CC2)C(=O)CNC(c3ccccc3)c4ccccc4</Smiles></StructureSmiles><PatentFamilies><PatentFamily id="1870636" number="EP-00525768" title="Tetralones with pharmacological activity."></PatentFamily></PatentFamilies><PatentFamilyCountsByTypes><PatentFamilyCountsByType><Type sortorder="12">Product</Type><Count>1</Count></PatentFamilyCountsByType></PatentFamilyCountsByTypes><PatentFamilyCountsByCompanies><PatentFamilyCountsByCompany><CompanyLink nameDisplay="Grupo Uriach" id="20513"></CompanyLink><CountAsOwner>1</CountAsOwner><CountAsThirdParty>0</CountAsThirdParty><CountTotal>1</CountTotal></PatentFamilyCountsByCompany></PatentFamilyCountsByCompanies><hasSWOTs>N</hasSWOTs></ns2:com.thomsonreuters.ls.service.contract.opportunitymonitor.v1.DrugRecordOutput>